APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bevacizumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bevacizumab Industry Growth and Trends Forecast to 2032

Report ID 173970150122 December 202593 pages

Choose your research edition.

Industry ResearchBevacizumab Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Bevacizumab Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Bevacizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bevacizumab Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Bevacizumab Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Bevacizumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bevacizumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bevacizumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bevacizumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bevacizumab include Mylan, Genentech, Amgen, MVASI (bevacizumab), Beacon Pharmaceuticals Limited, Balaji Medical Services Private Limited and Aark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bevacizumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bevacizumab market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bevacizumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bevacizumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bevacizumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bevacizumab Market by Company

Mylan

Genentech

Amgen

MVASI (bevacizumab)

Beacon Pharmaceuticals Limited

Balaji Medical Services Private Limited

Aark Pharmaceuticals

Bevacizumab Segment by Type

Avastin (bevacizumab)

Mvasi (bevacizumab-awwb)

Bevacizumab Segment by Application

Cancer

Eye Diease

Bevacizumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bevacizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bevacizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bevacizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bevacizumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bevacizumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Avastin (bevacizumab) Table 2. Major Company of Mvasi (bevacizumab-awwb) Table 3. Global Bevacizumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bevacizumab Sales by Type (2021-2026) & (k units) Table 5. Global Bevacizumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bevacizumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bevacizumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Bevacizumab Price by Type (2021-2026) & (US$/unit) Table 9. Global Bevacizumab Sales by Type (2027-2032) & (k units) Table 10. Global Bevacizumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bevacizumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bevacizumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Bevacizumab Price by Type (2027-2032) & (US$/unit) Table 14. North America Bevacizumab Sales by Type (2021-2026) & (k units) Table 15. North America Bevacizumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bevacizumab Sales by Type (2021-2026) & (k units) Table 17. Europe Bevacizumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bevacizumab Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Bevacizumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bevacizumab Sales by Type (2021-2026) & (k units) Table 21. Latin America Bevacizumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bevacizumab Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Bevacizumab Sales by Type (2021-2026) & (US$ Million) Table 24. Bevacizumab Industry Trends Table 25. Bevacizumab Industry Drivers Table 26. Bevacizumab Industry Opportunities and Challenges Table 27. Bevacizumab Industry Restraints Table 28. Global Bevacizumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bevacizumab Revenue Market Share by Company (2021-2026) Table 30. Global Bevacizumab Sales by Company (2021-2026) & (k units) Table 31. Global Bevacizumab Sales Share by Company (2021-2026) Table 32. Global Bevacizumab Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Bevacizumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bevacizumab Major Company Production Sites and Headquarters Table 35. Global Bevacizumab Company, Product Type & Application Table 36. Global Bevacizumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bevacizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bevacizumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bevacizumab Sales by Region (2021-2026) & (k units) Table 41. Global Bevacizumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bevacizumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bevacizumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Bevacizumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Bevacizumab Sales by Region (2027-2032) & (k units) Table 46. Global Bevacizumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bevacizumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bevacizumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Bevacizumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Bevacizumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bevacizumab Sales by Application (2021-2026) & (k units) Table 52. Global Bevacizumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bevacizumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bevacizumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Bevacizumab Price by Application (2021-2026) & (US$/unit) Table 56. Global Bevacizumab Sales by Application (2027-2032) & (k units) Table 57. Global Bevacizumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bevacizumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bevacizumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Bevacizumab Price by Application (2027-2032) & (US$/unit) Table 61. North America Bevacizumab Sales by Application (2021-2026) & (k units) Table 62. North America Bevacizumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bevacizumab Sales by Application (2021-2026) & (k units) Table 64. Europe Bevacizumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bevacizumab Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Bevacizumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bevacizumab Sales by Application (2021-2026) & (k units) Table 68. Latin America Bevacizumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bevacizumab Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Bevacizumab Sales by Application (2021-2026) & (US$ Million) Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Mylan Bevacizumab Product Portfolio Table 75. Mylan Recent Development Table 76. Genentech Company Information Table 77. Genentech Business Overview Table 78. Genentech Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Genentech Bevacizumab Product Portfolio Table 80. Genentech Recent Development Table 81. Amgen Company Information Table 82. Amgen Business Overview Table 83. Amgen Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Amgen Bevacizumab Product Portfolio Table 85. Amgen Recent Development Table 86. MVASI (bevacizumab) Company Information Table 87. MVASI (bevacizumab) Business Overview Table 88. MVASI (bevacizumab) Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. MVASI (bevacizumab) Bevacizumab Product Portfolio Table 90. MVASI (bevacizumab) Recent Development Table 91. Beacon Pharmaceuticals Limited Company Information Table 92. Beacon Pharmaceuticals Limited Business Overview Table 93. Beacon Pharmaceuticals Limited Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Beacon Pharmaceuticals Limited Bevacizumab Product Portfolio Table 95. Beacon Pharmaceuticals Limited Recent Development Table 96. Balaji Medical Services Private Limited Company Information Table 97. Balaji Medical Services Private Limited Business Overview Table 98. Balaji Medical Services Private Limited Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Balaji Medical Services Private Limited Bevacizumab Product Portfolio Table 100. Balaji Medical Services Private Limited Recent Development Table 101. Aark Pharmaceuticals Company Information Table 102. Aark Pharmaceuticals Business Overview Table 103. Aark Pharmaceuticals Bevacizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Aark Pharmaceuticals Bevacizumab Product Portfolio Table 105. Aark Pharmaceuticals Recent Development Table 106. North America Bevacizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Bevacizumab Sales by Country (2021-2026) & (k units) Table 108. North America Bevacizumab Sales Market Share by Country (2021-2026) Table 109. North America Bevacizumab Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Bevacizumab Sales Market Share Forecast by Country (2027-2032) Table 111. North America Bevacizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Bevacizumab Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Bevacizumab Market Share by Country (2021-2026) Table 114. North America Bevacizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Bevacizumab Market Share Forecast by Country (2027-2032) Table 116. Europe Bevacizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Bevacizumab Sales by Country (2021-2026) & (k units) Table 118. Europe Bevacizumab Sales Market Share by Country (2021-2026) Table 119. Europe Bevacizumab Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Bevacizumab Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Bevacizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Bevacizumab Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Bevacizumab Market Share by Country (2021-2026) Table 124. Europe Bevacizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Bevacizumab Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Bevacizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Bevacizumab Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Bevacizumab Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Bevacizumab Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Bevacizumab Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Bevacizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Bevacizumab Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Bevacizumab Market Share by Country (2021-2026) Table 134. Asia-Pacific Bevacizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Bevacizumab Market Share Forecast by Country (2027-2032) Table 136. Latin America Bevacizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Bevacizumab Sales by Country (2021-2026) & (k units) Table 138. Latin America Bevacizumab Sales Market Share by Country (2021-2026) Table 139. Latin America Bevacizumab Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Bevacizumab Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Bevacizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Bevacizumab Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Bevacizumab Market Share by Country (2021-2026) Table 144. Latin America Bevacizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Bevacizumab Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Bevacizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Bevacizumab Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Bevacizumab Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Bevacizumab Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Bevacizumab Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Bevacizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Bevacizumab Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Bevacizumab Market Share by Country (2021-2026) Table 154. Middle East and Africa Bevacizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Bevacizumab Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Bevacizumab Distributors List Table 159. Bevacizumab Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Bevacizumab Image Figure 2. Global Bevacizumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bevacizumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Bevacizumab Sales (2021-2032) & (k units) Figure 5. Avastin (bevacizumab) Image Figure 6. Global Avastin (bevacizumab) Sales YoY Growth (2021-2032) & (k units) Figure 7. Mvasi (bevacizumab-awwb) Image Figure 8. Global Mvasi (bevacizumab-awwb) Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Bevacizumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bevacizumab Market Share by Type 2025 VS 2032 Figure 11. North America Bevacizumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Bevacizumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Bevacizumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bevacizumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bevacizumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bevacizumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bevacizumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bevacizumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bevacizumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bevacizumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bevacizumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cancer Image Figure 24. Global Cancer Sales YoY Growth (2021-2032) & (k units) Figure 25. Eye Diease Image Figure 26. Global Eye Diease Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Bevacizumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Bevacizumab Market Share by Application 2025 VS 2032 Figure 29. North America Bevacizumab Sales Market Share in Volume by Application in 2025 Figure 30. North America Bevacizumab Sales Market Share in Value by Application in 2025 Figure 31. Europe Bevacizumab Sales Market Share in Volume by Application in 2025 Figure 32. Europe Bevacizumab Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Bevacizumab Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Bevacizumab Sales Market Share in Value by Application in 2025 Figure 35. Latin America Bevacizumab Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Bevacizumab Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Bevacizumab Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Bevacizumab Sales Market Share in Value by Application in 2025 Figure 39. North America Bevacizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Bevacizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Bevacizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Bevacizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Bevacizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Bevacizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bevacizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Bevacizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Bevacizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Bevacizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bevacizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Bevacizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Bevacizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Bevacizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bevacizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Bevacizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Bevacizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Bevacizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bevacizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Bevacizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Bevacizumab Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Bevacizumab Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Avastin (bevacizumab)
  • Mvasi (bevacizumab-awwb)
Applications
  • Cancer
  • Eye Diease
Companies covered
  • Mylan
  • Genentech
  • Amgen
  • MVASI (bevacizumab)
  • Beacon Pharmaceuticals Limited
  • Balaji Medical Services Private Limited
  • Aark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bevacizumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bevacizumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bevacizumab Market by Type
  6. 1.3.1 Avastin (bevacizumab)
  7. 1.3.2 Mvasi (bevacizumab-awwb)
  8. 1.4 Global Bevacizumab Market Size by Type
  9. 1.4.1 Global Bevacizumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bevacizumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bevacizumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bevacizumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bevacizumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bevacizumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bevacizumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bevacizumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bevacizumab Industry Trends
  2. 2.2 Bevacizumab Industry Drivers
  3. 2.3 Bevacizumab Industry Opportunities and Challenges
  4. 2.4 Bevacizumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bevacizumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Bevacizumab Sales (2021-2026)
  3. 3.3 Global Top Players by Bevacizumab Price (2021-2026)
  4. 3.4 Global Bevacizumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bevacizumab Major Company Production Sites & Headquarters
  6. 3.6 Global Bevacizumab Company, Product Type & Application
  7. 3.7 Global Bevacizumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bevacizumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bevacizumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bevacizumab Tier 1, Tier 2, and Tier 3
4 Bevacizumab Regional Status and Outlook
  1. 4.1 Global Bevacizumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bevacizumab Historic Market Size by Region
  3. 4.2.1 Global Bevacizumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bevacizumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bevacizumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bevacizumab Forecasted Market Size by Region
  7. 4.3.1 Global Bevacizumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bevacizumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bevacizumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bevacizumab by Application
  1. 5.1 Bevacizumab Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Eye Diease
  4. 5.2 Global Bevacizumab Market Size by Application
  5. 5.2.1 Global Bevacizumab Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Bevacizumab Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Bevacizumab Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Bevacizumab Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Bevacizumab Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Bevacizumab Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Bevacizumab Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Bevacizumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Mylan
  2. 6.1.1 Mylan Company Information
  3. 6.1.2 Mylan Business Overview
  4. 6.1.3 Mylan Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Mylan Bevacizumab Product Portfolio
  6. 6.1.5 Mylan Recent Developments
  7. 6.2 Genentech
  8. 6.2.1 Genentech Company Information
  9. 6.2.2 Genentech Business Overview
  10. 6.2.3 Genentech Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Genentech Bevacizumab Product Portfolio
  12. 6.2.5 Genentech Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Bevacizumab Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 MVASI (bevacizumab)
  20. 6.4.1 MVASI (bevacizumab) Company Information
  21. 6.4.2 MVASI (bevacizumab) Business Overview
  22. 6.4.3 MVASI (bevacizumab) Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MVASI (bevacizumab) Bevacizumab Product Portfolio
  24. 6.4.5 MVASI (bevacizumab) Recent Developments
  25. 6.5 Beacon Pharmaceuticals Limited
  26. 6.5.1 Beacon Pharmaceuticals Limited Company Information
  27. 6.5.2 Beacon Pharmaceuticals Limited Business Overview
  28. 6.5.3 Beacon Pharmaceuticals Limited Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beacon Pharmaceuticals Limited Bevacizumab Product Portfolio
  30. 6.5.5 Beacon Pharmaceuticals Limited Recent Developments
  31. 6.6 Balaji Medical Services Private Limited
  32. 6.6.1 Balaji Medical Services Private Limited Company Information
  33. 6.6.2 Balaji Medical Services Private Limited Business Overview
  34. 6.6.3 Balaji Medical Services Private Limited Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Balaji Medical Services Private Limited Bevacizumab Product Portfolio
  36. 6.6.5 Balaji Medical Services Private Limited Recent Developments
  37. 6.7 Aark Pharmaceuticals
  38. 6.7.1 Aark Pharmaceuticals Company Information
  39. 6.7.2 Aark Pharmaceuticals Business Overview
  40. 6.7.3 Aark Pharmaceuticals Bevacizumab Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aark Pharmaceuticals Bevacizumab Product Portfolio
  42. 6.7.5 Aark Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Bevacizumab Sales by Country
  2. 7.1.1 North America Bevacizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bevacizumab Sales by Country (2021-2026)
  4. 7.1.3 North America Bevacizumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bevacizumab Market Size by Country
  6. 7.2.1 North America Bevacizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bevacizumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Bevacizumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bevacizumab Sales by Country
  2. 8.1.1 Europe Bevacizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bevacizumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Bevacizumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bevacizumab Market Size by Country
  6. 8.2.1 Europe Bevacizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bevacizumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bevacizumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bevacizumab Sales by Country
  2. 9.1.1 Asia-Pacific Bevacizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bevacizumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bevacizumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bevacizumab Market Size by Country
  6. 9.2.1 Asia-Pacific Bevacizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bevacizumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bevacizumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bevacizumab Sales by Country
  2. 10.1.1 South America Bevacizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bevacizumab Sales by Country (2021-2026)
  4. 10.1.3 South America Bevacizumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bevacizumab Market Size by Country
  6. 10.2.1 South America Bevacizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bevacizumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Bevacizumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bevacizumab Sales by Country
  2. 11.1.1 Middle East and Africa Bevacizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bevacizumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bevacizumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bevacizumab Market Size by Country
  6. 11.2.1 Middle East and Africa Bevacizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bevacizumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bevacizumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bevacizumab Value Chain Analysis
  2. 12.1.1 Bevacizumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bevacizumab Production Mode & Process
  7. 12.2 Bevacizumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bevacizumab Distributors
  10. 12.2.3 Bevacizumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst